475 related articles for article (PubMed ID: 15613403)
1. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.
Harper L; Savage CO
Rheumatology (Oxford); 2005 Apr; 44(4):495-501. PubMed ID: 15613403
[TBL] [Abstract][Full Text] [Related]
2. ANCA-associated vasculitis with renal involvement: an outcome analysis.
Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
[TBL] [Abstract][Full Text] [Related]
3. Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.
Bakoush O; Segelmark M; Torffvit O; Ohlsson S; Tencer J
Nephrol Dial Transplant; 2006 May; 21(5):1263-9. PubMed ID: 16449276
[TBL] [Abstract][Full Text] [Related]
4. Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy.
Cohen BA; Clark WF
Am J Kidney Dis; 2000 Nov; 36(5):914-24. PubMed ID: 11054347
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement.
Rihova Z; Jancova E; Merta M; Rysava R; Reiterova J; Zabka J; Tesar V
Kidney Blood Press Res; 2005; 28(3):144-52. PubMed ID: 15908752
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
[TBL] [Abstract][Full Text] [Related]
7. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
Booth AD; Almond MK; Burns A; Ellis P; Gaskin G; Neild GH; Plaisance M; Pusey CD; Jayne DR;
Am J Kidney Dis; 2003 Apr; 41(4):776-84. PubMed ID: 12666064
[TBL] [Abstract][Full Text] [Related]
8. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
9. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845
[TBL] [Abstract][Full Text] [Related]
10. Predictors of damage and survival in patients with Wegener's granulomatosis: analysis of 50 patients.
Kamali S; Erer B; Artim-Esen B; Gul A; Ocal L; Konice M; Aral O; Inanc M
J Rheumatol; 2010 Feb; 37(2):374-8. PubMed ID: 20008921
[TBL] [Abstract][Full Text] [Related]
11. ANCA-associated renal vasculitis--epidemiology, diagnostics and treatment.
Ríhová Z; Jancová E; Merta M; Tesar V
Prague Med Rep; 2004; 105(3):237-60. PubMed ID: 15782551
[TBL] [Abstract][Full Text] [Related]
12. Malignancy is increased in ANCA-associated vasculitis.
Pankhurst T; Savage CO; Gordon C; Harper L
Rheumatology (Oxford); 2004 Dec; 43(12):1532-5. PubMed ID: 15316126
[TBL] [Abstract][Full Text] [Related]
13. An index for renal outcome in ANCA-associated glomerulonephritis.
Vergunst CE; van Gurp E; Hagen EC; van Houwelingen HC; Hauer HA; Noël LH; Waldherr R; Ferrario F; van der Woude FJ; Bruijn JA; Bajema IM;
Am J Kidney Dis; 2003 Mar; 41(3):532-8. PubMed ID: 12612975
[TBL] [Abstract][Full Text] [Related]
14. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.
de Lind van Wijngaarden RA; Hauer HA; Wolterbeek R; Jayne DR; Gaskin G; Rasmussen N; Noël LH; Ferrario F; Waldherr R; Hagen EC; Bruijn JA; Bajema IM
J Am Soc Nephrol; 2006 Aug; 17(8):2264-74. PubMed ID: 16825335
[TBL] [Abstract][Full Text] [Related]
15. The clinical and pathological characteristics of Chinese elderly patients with anti-neutrophil cytoplasmic autoantibodies associated small vessel vasculitis.
Wang Y; Zhao MH; Yu J; Xin G; Liu YC; Zhang YK; Wang HY
Exp Gerontol; 2004 Sep; 39(9):1401-5. PubMed ID: 15489063
[TBL] [Abstract][Full Text] [Related]
16. ANCA-negative pauci-immune renal vasculitis: histology and outcome.
Eisenberger U; Fakhouri F; Vanhille P; Beaufils H; Mahr A; Guillevin L; Lesavre P; Noël LH
Nephrol Dial Transplant; 2005 Jul; 20(7):1392-9. PubMed ID: 15855209
[TBL] [Abstract][Full Text] [Related]
17. [Wegener granulomatosis and microscopic polyangiitis. Diagnostic and clinical results in 54 patients with long-term follow-up].
Bolley R; Mistry-Burchardi N; Samtleben W
Dtsch Med Wochenschr; 2000 Dec; 125(50):1519-25. PubMed ID: 11190761
[TBL] [Abstract][Full Text] [Related]
18. ANCA vasculitis in the elderly.
Hoganson DD; From AM; Michet CJ
J Clin Rheumatol; 2008 Apr; 14(2):78-81. PubMed ID: 18391675
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
Lurati-Ruiz F; Spertini F
J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696
[TBL] [Abstract][Full Text] [Related]
20. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
